The ventricular and atrium cardiac myosin at dilated cardiomyopathy: a comparative study of immunoreactivity
VI Bobyk, OM Fedorkova, DV Ryabenko… - Biopolymers and …, 1999 - biopolymers.org.ua
VI Bobyk, OM Fedorkova, DV Ryabenko, TV Kovenia, LL Sidorik, GK Matsuka
Biopolymers and Cell, 1999•biopolymers.org.uaThe peculiarities of the immune reaction against myosin, purified from atria and ventricular
myocardia in patients with dilated (DCM) and ischemic (ICM) cardiomyopathies were
investigated. The high level of antibodies against atria myosin was revealed in all sera.
However, the DCM patients characteristic was more significant cardiac ventricular myosin
immunoreactivity. Antibody-positive patients with high sera antibody level against myosin
purified from normal human and DCM affected ventricular myocardia were revealed more …
myocardia in patients with dilated (DCM) and ischemic (ICM) cardiomyopathies were
investigated. The high level of antibodies against atria myosin was revealed in all sera.
However, the DCM patients characteristic was more significant cardiac ventricular myosin
immunoreactivity. Antibody-positive patients with high sera antibody level against myosin
purified from normal human and DCM affected ventricular myocardia were revealed more …
The peculiarities of the immune reaction against myosin, purified from atria and ventricular myocardia in patients with dilated (DCM) and ischemic (ICM) cardiomyopathies were investigated. The high level of antibodies against atria myosin was revealed in all sera. However, the DCM patients characteristic was more significant cardiac ventricular myosin immunoreactivity. Antibody-positive patients with high sera antibody level against myosin purified from normal human and DCM affected ventricular myocardia were revealed more often in DCM than ICM patients group.
biopolymers.org.ua
以上显示的是最相近的搜索结果。 查看全部搜索结果